Admittedly, DKK3 functions as tumor suppressor and loss of DKK3 function is associated with poorer outcomes in DKK3 non-expressing tumors, such as prostate cancer and renal cancers, which is also confirmed by the analyses using by data in TCGA [15]. This evidence concerns the gene DKK3 and prostate cancer.